Corticosteroids have a well-established role in the treatment of sarcoidosis but their adverse effects limit their use as first-line therapy, especially when sarcoidosis involves solely the skin. Uncontrolled reports have proposed alternative treatments for sarcoidosis, such as antimalarials or methotrexate.1 However, indications are not well established.
We report herein a case of cutaneous sarcoidosis resistant to other conventional therapies, then successfully treated with thalidomide. We discuss the advantage of using this treatment in sarcoidosis.
Rousseau L, Beylot-Barry M, Doutre M, Beylot C. Cutaneous Sarcoidosis Successfully Treated With Low Doses of Thalidomide. Arch Dermatol. 1998;134(8):1045–1046. doi:
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: